Santen BeNeLux

Swiss Advanced Vision (SAV-IOL SA) offers the first Swiss made premium IOL with patented EDOF technology that prevents dysphotopsia by the creation of a non-diverging beam on the retina while providing a continuous vision (near-intermediate-far) to the patient.

SCHWIND eye-tech-solutions develops, produces and markets a comprehensive product portfolio for the treatment of ametropia and corneal diseases. It consists of an excimer lasers representing the forefront of technology today, a sophisticated modular planning software for a uniquely wide range of applications as well as diagnostic systems. The SCHWIND AMARIS product family of excimer lasers is available in three versions with pulse rates from 500 to 1050 Hertz and eye tracking from five to seven dimensions. The new SmartSurfACE procedure combines the features of touch-free TransPRK surface treatment with innovative SmartPulse Technology and accelerates visual acuity recovery after treatment.

Single antibiotic in multidose and unitdose preservative free presentations, and ophthalmic ointments Combination of antibiotics in multidose presentations, and ophthalmic ointments Combination of steroids and antibiotics in multidose and unit dose preservative free presentations, and ophthalmic ointments NSAIDs in multidose presentations Steroids in multidose and unit dose preservative free presentations, and ophthalmic ointments Tear substitutes in multidose and unit dose preservative free presentations Re-epithelializing agents in unit dose preservative free presentations Anti glaucoma treatment (ß-blockers, PGs, and ß-blockers/CAI Inhibitors combination) Nutraceuticals for Retina,Vitreous desease and neuroprotection Medical devices IOL’s and accessories for cataract surgery

SightLife, a non-profit global health organization, launched SightLife Surgical, a for-profit subsidiary, to infuse resources needed to accelerate the achievable mission of eliminating corneal blindness by 2040. SightLife Surgical is committed to providing innovation in research, products, prevention and policy to help the 10 million individuals living with treatable corneal blindness around the world. We passionately believe that everyone in need of a sight-restoring corneal treatment, anywhere in the world, should have access to the care they need.